1. Home
  2. DRTS vs LAES Comparison

DRTS vs LAES Comparison

Compare DRTS & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.52

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.98

Market Cap

606.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
LAES
Founded
2015
2022
Country
Israel
Switzerland
Employees
121
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
641.6M
606.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
DRTS
LAES
Price
$7.52
$2.98
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$8.67
$4.00
AVG Volume (30 Days)
330.6K
12.1M
Earning Date
05-18-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$93.36
Revenue Next Year
$699.98
$43.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.99
52 Week High
$8.80
$8.71

Technical Indicators

Market Signals
Indicator
DRTS
LAES
Relative Strength Index (RSI) 48.11 54.04
Support Level $6.47 $2.54
Resistance Level $7.75 $3.28
Average True Range (ATR) 0.56 0.23
MACD -0.02 0.06
Stochastic Oscillator 19.00 57.18

Price Performance

Historical Comparison
DRTS
LAES

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

Share on Social Networks: